TNF Pharmaceuticals - Rentabilitas operasi TNFA

TNFA (TNF Pharmaceuticals Inc.) - tandha merek perusahaan

TNF Pharmaceuticals adheres to environmental standards in its laboratories by minimizing bio-waste. TNF Pharmaceuticals is developing unique anti-inflammatory methods, competing through its patent portfolio. However, the lack of stable revenue and the risks of failed tests create a threat of devaluation. The GURU.Markets terminal displays a chart of the core business margin, where 0.00 reflects the latest metric value, helping to assess the business's resilience.

TNFA: Tingkat bathi operasi TNF Pharmaceuticals Inc. 25.07.2024 - 25.09.2025

TNF Pharma - rincian analitis lan metrik utama (TNFA)

Analisis komprehensif perusahaan:tnfpharma.com, TNFA
Barang utama TNF Pharmaceuticals Inc.

This indicator measures the share of operating profit in total revenue, allowing for an assessment of production process efficiency before accounting for debt obligations and taxes. An analysis of the core business margin reveals a critical gap between R&D expenditures and the lack of commercial products from TNF Pharmaceuticals (TNFA), which renders current operating efficiency negative due to the specific nature of a biotechnology startup.

Pesaing utama

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|Aquestive Therapeutics, Inc. - Margin operasi|scpharmaceuticals.com - Rasio bathi operasi|Tectonic (TECX) - Rentabilitas operasi|Margin dodolan operasi Tonix Pharmaceuticals Inc.|Rentabilitas operasi sxtchina.com|Margin dodolan operasi Eupraxia Pharmaceuticals (EPRX)|Margin operasi BHST|EXOZ - Rentabilitas dodolan operasi|Oramed - Margin dodolan operasi|Entera Bio Ltd. (ENTX) - Rentabilitas dodolan operasi|HYFT - Rentabilitas operasi|ABVC: Rentabilitas operasi|CPIX: Margin operasi|Quantum BioPharma Ltd. - Tingkat bathi operasi|FGEN (FibroGen Corp) - Margin operasi|Telomir Pharma (TELO) - Rentabilitas kegiatan operasi|Rentabilitas operasi Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Tingkat bathi operasi|Rentabilitas operasi Rallybio Corporation RLYB|LEXX: Rentabilitas dodolan miturut bathi operasi|PULM - Rentabilitas operasi|Tingkat bathi operasi PTHL (Pheton Holdings)|Aptorum (APM) - Rentabilitas operasi|LYRA (Lyra Therapeutics) - Rentabilitas operasi|Rentabilitas operasi Impact BioMedical Inc|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.